Report: Nearly 80% of U.S. prescriptions are for generic drugs

DUBLIN — The United States is the biggest generic drugs market in the world, with nearly 80% of prescriptions in American written for generics, according to Research and Markets’ “Analyzing the Generic Drugs Sector of the U.S. Pharmaceutical Industry 2017.”

The report also includes a section called “Promoting Generic Drug Competition in the US Market,” which covers topics such as issues with the FDA Approval Process, the role of the Orange Book, the positive and negative outcomes of the Hatch Waxman Act, the manipulation of this act, promoting methods for generic drug availability, amongst other points of discussion.

Also includes are strategies for survival employed by branded manufacturers, the role of generic drugs in lowering US drug re-importation, a case study on generic antidepressants, the approval of the generic version of GSK's drug Coreg, the introduction of Bill S.438, and the substantial move by Blue Cross in major changes to its drug plans, are discussed and analyzed in this report.

In addition, covered in the report is an analysis of major industry players, such as Teva, Mylan, Sandoz and Sanofi.

For more information about the report, click here.